Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia

Journal of Vascular Surgery

Volumn 57, Issue 1, 2013, Pages

  Nakanishi, Keisuke ^a   Saito, Yukihiro ^a   Azuma, Nobuyoshi ^a   Sasajima, Tadahiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LIM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3;

AGED; ARTICLE; BINDING KINETICS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME ACTIVATION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYPERPLASIA; INTIMAL HYPERPLASIA; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VEIN GRAFT;

EID: 84871614491     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.06.082     Document Type: Article

References (35)

1. R.P. Leather, D.M. Shah, B.B. Chang, J.L. Kaufman Resurrection of the in situ saphenous vein bypass 1000 cases later Ann Surg 208 1988 435 442
2. D. Buchbinder, D.L. Rollins, C.M. Semrow, J.J. Schuler, J.P. Meyer, D.P. Flanigan In situ tibial reconstruction State-of-the-art or passing fancy Ann Surg 207 1988 184 188
3. J.G. Motwani, E.J. Topol Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention Circulation 97 1998 916 931
4. H.D. Berkowitz, S. Greenstein, C.F. Barker, L.J. Perloff Late failure of reversed vein bypass grafts Ann Surg 210 1989 782 786
5. L.M. Taylor Jr, J.M. Edwards, J.M. Porter Present status of reversed vein bypass grafting: five-year results of a modern series J Vasc Surg 11 1990 193 205 discussion:205-196
6. M.A. Fogle, A.D. Whittemore, N.P. Couch, J.A. Mannick A comparison of in situ and reversed saphenous vein grafts for infrainguinal reconstruction J Vasc Surg 5 1987 46 52
7. J.J. Hurley, A.I. Auer, H.B. Binnington, F.B. Hershey, E.E. Swensson, J.J. Woods Jr Comparison of initial limb salvage in 98 consecutive patients with either reversed autogenous or in situ vein bypass graft procedures Am J Surg 150 1985 777 781
8. M.S. Conte, D.F. Bandyk, A.W. Clowes, G.L. Moneta, L. Seely, T.J. Lorenz Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery J Vasc Surg 43 2006 742 751 discussion 751
9. A. Ehsan, M.J. Mann, G. Dell'Acqua, V.J. Dzau Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy J Thorac Cardiovasc Surg 121 2001 714 722
10. M.J. Mann, A.D. Whittemore, M.C. Donaldson, M. Belkin, M.S. Conte, J.F. Polak Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 1999 1493 1498
11. J.H. Alexander, G. Hafley, R.A. Harrington, E.D. Peterson, T.B. Ferguson Jr, T.J. Lorenz Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454
12. A.W. Clowes, S.M. Schwartz Significance of quiescent smooth muscle migration in the injured rat carotid artery Circ Res 56 1985 139 145
13. A.K. Mitra, D.M. Gangahar, D.K. Agrawal Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia Immunol Cell Biol 84 2006 115 124
14. T. Zubilewicz, J. Wronski, A. Bourriez, P. Terlecki, A.M. Guinault, B. Muscatelli-Groux Injury in vascular surgery-the intimal hyperplastic response Med Sci Monit 7 2001 316 324
15. M. Mayr, C. Li, Y. Zou, U. Huemer, Y. Hu, Q. Xu Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases FASEB J 14 2000 261 270
16. M. Sata, Y. Maejima, F. Adachi, K. Fukino, A. Saiura, S. Sugiura A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia J Mol Cell Cardiol 32 2000 2097 2104
17. J. Suzuki, M. Ogawa, K. Takayama, Y. Taniyama, R. Morishita, Y. Hirata Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice J Am Coll Cardiol 55 2010 904 913
18. Y. Taniyama, K. Tachibana, K. Hiraoka, T. Namba, K. Yamasaki, N. Hashiya Local delivery of plasmid DNA into rat carotid artery using ultrasound Circulation 105 2002 1233 1239
19. M. Johannessen, M.P. Delghandi, U. Moens What turns CREB on? Cell Signal 16 2004 1211 1227
20. G.M. Fimia, D. De Cesare, P. Sassone-Corsi A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM Mol Cell Biol 20 2000 8613 8622
21. E.T. Maizels, A. Mukherjee, G. Sithanandam, C.A. Peters, J. Cottom, K.E. Mayo Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat Mol Endocrinol 15 2001 716 733
22. C. Desdouets, G. Matesic, C.A. Molina, N.S. Foulkes, P. Sassone-Corsi, C. Brechot Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM Mol Cell Biol 15 1995 3301 3309
23. H. Ono, T. Ichiki, K. Fukuyama, N. Iino, S. Masuda, K. Egashira cAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration Arterioscler Thromb Vasc Biol 24 2004 1634 1639
24. T. Tokunou, R. Shibata, H. Kai, T. Ichiki, T. Morisaki, K. Fukuyama Apoptosis induced by inhibition of cyclic AMP response element-binding protein in vascular smooth muscle cells Circulation 108 2003 1246 1252
25. K.R. Chava, M. Karpurapu, D. Wang, M. Bhanoori, V. Kundumani-Sridharan, Q. Zhang CREB-mediated IL-6 expression is required for 15(S)- hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration Arterioscler Thromb Vasc Biol 29 2009 809 815
26. M.M. McLaughlin, S. Kumar, P.C. McDonnell, S. Van Horn, J.C. Lee, G.P. Livi Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase J Biol Chem 271 1996 8488 8492
27. G. Sithanandam, F. Latif, F.M. Duh, R. Bernal, U. Smola, H. Li 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region Mol Cell Biol 16 1996 868 876
28. T. Tanoue, R. Maeda, M. Adachi, E. Nishida Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions EMBO J 20 2001 466 479
29. G.M. Fimia, D. De Cesare, P. Sassone-Corsi CBP-independent activation of CREM and CREB by the LIM-only protein ACT Nature 398 1999 165 169
30. M.J. Morgan, S.A. Whawell The structure of the human LIM protein ACT gene and its expression in tumor cell lines Biochem Biophys Res Commun 273 2000 776 783
31. M.D. Conkright, E. Guzmán, L. Flechner, A.I. Su, J.B. Hogenesch, M. Montminy Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness Mol Cell 11 2003 1101 1108
32. I.E. Schauer, L.A. Knaub, M. Lloyd, P.A. Watson, C. Gliwa, K.E. Lewis CREB downregulation in vascular disease: a common response to cardiovascular risk Arterioscler Thromb Vasc Biol 30 2010 733 741
33. W.J. Chen, Y.H. Chen, K.H. Lin, C.H. Ting, Y.H. Yeh Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway Arterioscler Thromb Vasc Biol 31 2011 2106 2113
34. T. Ichiki Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both? Arterioscler Thromb Vasc Biol 26 2006 449 455
35. J.E. Reusch, D.J. Klemm Cyclic AMP response element-binding protein in the vessel wall: good or bad? Circulation 108 2003 1164 1166